全部

1·The invention relates to the inhibition of histone deacetylase.

本发明涉及组蛋白脱乙酰基酶的抑制。

2·The pharmacological actions of histone deacetylase inhibitors and their potential clinic…

综述了组蛋白去乙酰酶抑制剂的药理作用及其临床应用前景。

3·To reverse the memory loss, doctors inject a compound called a histone deacetylase inhibitor.

为了逆转记忆遗失，医生在复合物中添加了组蛋白脱乙酰基酶抑制物。

4·The pharmacological actions of histone deacetylase inhibitors and their potential clinical use…

综述了组蛋白去乙酰酶抑制剂的药理作用及其临床应用前景。

5·SITR1 is a histone deacetylase, a protein that blocks transcription factors from regulating genes.

SITR 1是一种组蛋白脱乙酰基酶，一种能够阻断来自调节基因的转录因子的蛋白质。

6·Sensitive assay system for inhibitor screening and kinetic assays of HDAC1 (histone deacetylase 1).

一种用于抑制剂筛选和HDAC1动力学检测的敏感检测系统。

7·The invention provides compounds and methods for inhibiting histone deacetylase enzymatic activity.

本发明提供了用于抑制组蛋白脱乙酰基酶酶活性的化合物和方法。

8·The present invention relates to hydroxamic acid derivatives that are inhibitors of histone deacetylase (HDAC).

本发明涉及作为组蛋白脱乙酰基酶（HDAC）抑制剂的异羟肟酸衍 生物。

9·Histone deacetylase inhibitors decrease the antigen presenting activity of murine bone marrow derived dendritic cells.

组蛋白去乙酰酶抑制剂降低抗原提呈小鼠骨髓来源的树突状细胞的活性。

10·Romidepsin is a potent histone deacetylase inhibitor, and is used in the treatment of cutaneous T-cell lymphoma (CTCL).

抗肿瘤药罗米地辛是一种有效的组蛋白去乙酰化酶抑制剂，临床 上用于治疗皮肤T细胞淋巴瘤。